2013•Immunological JournalRequires access

Effects of LPS stimulation on phenotype and functions of 1, 25(OH)_2D_3-treated dendritic cells

Ying Huang

Open publisher page 0 citations

Abstract

This study designed to investigate the effects of LPS stimulation on phenotype and functions of 1,25-dihydroxyvitamin D3(1, 25(OH)2D3)-treated dendritic cells(DC) in vitro. Firstly, 1, 25(OH)2D3-treated DC(10-8mol/L) were stimulated by LPS for 24 hours. Then the morphology of DC was observed by inverted microscopy; the expression of co-stimulatory molecules(CD80, CD86, and CD40) and MHC class Ⅱ was determined by flow cytometry; the levels of IL-12p70 and IL-10 were analyzed by ELISA. Furthermore, the capability of stimulating allogeneic CD4+T cell proliferation was measured by MLR(mixed lymphocyte reaction).1, 25(OH)2D3-treated DC stimulated by LPS exhibited features of inmature DC with high expression of costimulatory molecules CD86 and MHC class Ⅱ, inhibiting the secretion of IL-12p70, enhancing the secretion of IL-10, and suppressing allogeneic CD4+T cell proliferation. Results in this study indicate that 1, 25(OH)2D3-treated DC have the character of tolerogenic DCs, which can inhibit LPS-drived proliferation of CD4+T cells, which should be a foundation for study of 1, 25(OH)2D3-treated DCs inducing immunotolerance and the treatment of autoimmune disease such as asthma.

About this research paper

What this paper is about

This study designed to investigate the effects of LPS stimulation on phenotype and functions of 1,25-dihydroxyvitamin D3(1, 25(OH)2D3)-treated dendritic cells(DC) in vitro. Firstly, 1, 25(OH)2D3-treated DC(10-8mol/L) were stimulated by LPS for 24 hours. Then the morphology of DC was observed by inverted microscopy; the expression of co-stimulatory molecules(CD80, CD86, and CD40) and MHC class Ⅱ was determined by flow cytometry; the levels of IL-12p70 and IL-10 were analyzed by ELISA. Furthermore, the capability of stimulating allogeneic CD4+T cell proliferation was measured by MLR(mixed lymphocyte reaction).1, 25(OH)2D3-treated DC stimulated by LPS exhibited features of inmature DC with high expression of costimulatory molecules CD86 and MHC class Ⅱ, inhibiting the secretion of IL-12p70, enhancing the secretion of IL-10, and suppressing allogeneic CD4+T cell proliferation. Results in this study indicate that 1, 25(OH)2D3-treated DC have the character of tolerogenic DCs, which can inhibit LPS-drived proliferation of CD4+T cells, which should be a foundation for study of 1, 25(OH)2D3-treated DCs inducing immunotolerance and the treatment of autoimmune disease such as asthma.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

This study designed to investigate the effects of LPS stimulation on phenotype and functions of 1,25-dihydroxyvitamin D3(1, 25(OH)2D3)-treated dendritic cells(DC) in vitro. Firstly, 1, 25(OH)2D3-treated DC(10-8mol/L) were stimulated by LPS for 24 hours. Then the morphology of DC was observed by inverted microscopy; the expression of co-stimulatory molecules(CD80, CD86, and CD40) and MHC class Ⅱ was determined by flow cytometry; the levels of IL-12p70 and IL-10 were analyzed by ELISA. Furthermore, the capability of stimulating allogeneic CD4+T cell proliferation was measured by MLR(mixed lymphocyte reaction).1, 25(OH)2D3-treated DC stimulated by LPS exhibited features of inmature DC with high expression of costimulatory molecules CD86 and MHC class Ⅱ, inhibiting the secretion of IL-12p70, enhancing the secretion of IL-10, and suppressing allogeneic CD4+T cell proliferation. Results in this study indicate that 1, 25(OH)2D3-treated DC have the character of tolerogenic DCs, which can inhibit LPS-drived proliferation of CD4+T cells, which should be a foundation for study of 1, 25(OH)2D3-treated DCs inducing immunotolerance and the treatment of autoimmune disease such as asthma.

Key concepts: CD80, CD86, Mixed lymphocyte reaction, CD40, Dendritic cell, MHC class II, Chemistry, Stimulation

Related papers

Back to paper searchBrowse research topicsOriginal source
Effects of LPS stimulation on phenotype and functions of 1, 25(OH)_2D_3-treated dendritic cells — Research Paper | ScholarLens